5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Gland Pharma Ltd.

•
glandpharma.comBSE: 543245NSE: GLAND
Market Cap₹ 49,901 Cr.
Current Price
High / Low₹ 3,042 / 1,574
Stock P/E35.8
Book Value₹ 675
Price to Book2.60
Dividend Yield0.66 %
ROCE17.2 %
ROE12.7 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Latest quarter profit grew 35.3% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 0.97x)
  • Company generates healthy free cash flow

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Company has delivered a poor profit growth of 5.4% over past five years
  • Company has delivered a poor sales growth of 5.6% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY PHARMANIFTY MNCNIFTY TOTAL MKTNIFTY SMLCAP 50NIFTY 500
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.GLAND3024.9044.2149900.770.66316.9647.091800.2719.5714.9627.18
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
8841,0111,0981,1751,0121,0631,0111,0301,0391,0741,1781,2621,287
625664728742718699620636680699756754858
Operating Profit259347369433294364391394359375422508429
OPM %29.34%34.34%33.66%36.84%29.01%34.22%38.70%38.25%34.54%34.90%35.81%40.24%33.33%
354143474858654455833610659
Interest21151018374061
Depreciation39404043414244434445454344
Profit before Tax254347372433300380394391362409412565488
Tax %26.15%25.80%25.54%25.72%25.77%25.83%25.12%25.89%25.70%26.10%25.36%25.56%25.28%
Net Profit188258277321223282295290269302308420364
11.3915.6416.8119.5113.5317.1017.9117.6016.3418.3318.6825.5222.11

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,4791,6202,0442,6333,4634,4013,6174,1674,1164,5524,800
8541,0851,3381,6782,1612,8902,5982,7592,6742,8893,067
Operating Profit6255357069551,3021,5111,0191,4091,4431,6631,733
OPM %42.25%33.03%34.55%36.28%37.61%34.33%28.16%33.80%35.05%36.53%36.11%
344966139135224184167215280284
Interest64473578231811
Depreciation7478829599110147162169176176
Profit before Tax5785026869931,3351,6191,0481,4051,4661,7481,874
Tax %28.42%35.98%34.16%22.16%25.31%25.13%26.00%25.77%25.64%25.67%25.56%
Net Profit4143214527739971,2127761,0431,0901,3001,395
EPS267.01207.24291.6549.8862.9973.6747.1163.3466.1478.88—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%31.57%27.21%25.36%—

COMPOUNDED SALES GROWTH

10 Years:
13%
5 Years:
6%
3 Years:
8%

COMPOUNDED PROFIT GROWTH

10 Years:
15%
5 Years:
5%
3 Years:
19%

STOCK PRICE CAGR

10 Years:
—
5 Years:
-5%
3 Years:
20%
1 Year:
55%

RETURN ON EQUITY

10 Years:
16%
5 Years:
13%
3 Years:
12%
Last Year:
13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Aug 11

₹ 20

Rs.20.0000 per share(2000%)Final Dividend

2025

Aug 14

₹ 18

Rs.18.0000 per share(1800%)Final Dividend

2024

Aug 16

₹ 20

Rs.20.0000 per share(2000%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital15151515161616161616
2,0742,3952,8473,6145,8627,1297,9358,9779,73910,748
4544207665342
Trade Payables189292446249396463589281386485
149182194200215220227263277355
Total Liabilities2,4742,9283,5234,0866,4967,8348,7739,54110,42211,607
8728439299689541,5021,5711,6941,7451,688
Capital Work in Progress16119912318833818117712042138
0000116382,3862,7903,293
3795139127561,2751,1861,9451,2601,2541,265
00000001,1711,1431,521
Cash & Bank5336717531,3253,0053,0863,7671,5992,4333,178
5297038058489231,7171,3051,3111,015525
Total Assets2,4742,9283,5234,0866,4967,8348,7739,54110,42211,607

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
6383594099459161,1986791,1361,0741,135
Cash from Investing-97-359-314-766-1,525-1,0101,208-2,9241,578-96
Cash from Financing-116-4-3-71,2383515-7-340-316
263-160-132-72319-1841,591-1,7952,312723

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
51.8351.8351.8351.8351.8351.8351.8351.8351.77
6.884.485.046.907.397.907.587.298.74
32.8335.3734.8033.2732.8632.6332.9933.3630.44
Government0.000.000.000.000.000.000.000.000.00
8.458.328.337.997.937.637.617.529.05

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-10 - Gland Pharma Limited has informed the Exchange about Schedule of meet

2026-09-08
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-08 - Gland Pharma Limited has informed the Exchange about Schedule of meet

2026-09-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-04 - Gland Pharma Limited has informed the Exchange about Schedule of meet

2026-09-01
General Updates

2026-09-01 - Gland Pharma Limited has informed the Exchange about General Updates

2026-08-31
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-31 - Gland Pharma Limited has informed the Exchange about Schedule of meet

2026-08-26
Shareholders meeting

2026-08-26 - Gland Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 25, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-25
Shareholders meeting

2026-08-25 - Gland Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2026

2026-08-23
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-23 - Gland Pharma Limited has informed the Exchange about Schedule of meet

2026-08-17
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-17 - Gland Pharma Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for GLAND

Loading news…

🤖

AI Stock Analyst

Gland Pharma Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login